[HTML][HTML] All-cause mortality among patients treated with repurposed antivirals and antibiotics for COVID-19 in Mexico City: A real-world observational study

…, J Márquez-Sánchez, RE Reyes-Casarrubias… - EXCLI …, 2021 - ncbi.nlm.nih.gov
The aim of our study was to evaluate all-cause mortality risk in patients with laboratory-confirmed
COVID-19 in Mexico City treated with repurposed antivirals and antibiotics. This real-…

Use of antivirals and antibiotics for COVID-19 in Mexico City: a real-world Multicenter Cohort Study

…, J Marquez-Sanchez, RE Reyes-Casarrubias… - 2020 - pesquisa.bvsalud.org
AimTo evaluate all-cause mortality risk in patients with laboratory-confirmed COVID-19 in
Mexico City treated with repurposed antivirals and antibiotics. MethodsThis real-world …

Use of antivirals and antibiotics for COVID-19 in Mexico City: A Real-World Multicenter Cohort Study (preprint)

…, J Marquez-Sanchez, RE Reyes-Casarrubias… - 2020 - pesquisa.bvsalud.org
AimTo evaluate all-cause mortality risk in patients with laboratory-confirmed COVID-19 in
Mexico City treated with repurposed antivirals and antibiotics. MethodsThis real-world …

[CITATION][C] All-cause mortality among patients treated with repurposed antivirals and antibiotics for COVID-19 in Mexico City: A Real-World Observational Study

JM GALINDO, JÓG Méndez, JM Sánchez… - www. medrxiv. org, 2021

[PDF][PDF] Use of antivirals and antibiotics for COVID-19 in Mexico City: A Real-World Multicenter Cohort Study

J Márquez-Sánchez - researchgate.net
We aimed to characterize real-world use of antivirals and antibiotics in patients with COVID-19
and their associations with mortality. We conducted a real-world retrospective cohort …